It may be a mechanism of cancer immune evasion, and this mechanism-driving overexpression in tumor cells seems to be a compensatory response to a pro-inflammatory tumor microenvironment with high levels of TNF-α (42), which activates NF-κB signaling and thus regulates CD47 expression (43). The gene discussed is CD47; the disease is cancer.